Zhao, Y., Griesel, R., Omar, Z., Simmons, B., Hill, A., van Zyl, G., . . . Meintjes, G. (2023). Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: A noncomparative, double-blind, randomized placebo-controlled trial. Oxford University Press.

Zhao, Y., R. Griesel, Z. Omar, B. Simmons, A. Hill, G. van Zyl, C. Keene, G. Maartens, and G. Meintjes. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.

Zhao, Y., et al. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.